SecSonar.com

Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Orchestra BioMed Holdings, Inc. (OBIO) is a Biotechnology company based in US with a market capitalization of $236.8M. Revenue grew 1169.2% year-over-year and free cash flow was negative at -$49.5M. This page tracks OBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 70 employees · IPO Aug 4, 2020

Valuation

Valuation & price

$3.72 · as of May 17, 2026 · -30.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

3.74

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.35$3.88$2.42Jul 25Dec 25Jul 26Jul 7, 25$2.89Jul 9, 25$2.98Jul 11, 25$2.92Jul 15, 25$2.92Jul 17, 25$3.17Jul 21, 25$3.16Jul 23, 25$3.19Jul 25, 25$3.29Jul 29, 25$3.16Jul 31, 25$3.06Aug 4, 25$2.68Aug 6, 25$2.64Aug 11, 25$2.52Aug 13, 25$2.66Aug 15, 25$2.57Aug 19, 25$2.55Aug 21, 25$2.49Aug 25, 25$2.60Aug 27, 25$2.84Aug 29, 25$2.73Sep 3, 25$2.72Sep 5, 25$2.75Sep 9, 25$2.71Sep 11, 25$2.62Sep 16, 25$2.53Sep 18, 25$2.51Sep 22, 25$2.45Sep 24, 25$2.42Sep 26, 25$2.42Sep 30, 25$2.48Oct 2, 25$2.68Oct 6, 25$2.77Oct 8, 25$2.90Oct 10, 25$3.15Oct 14, 25$3.56Oct 16, 25$3.68Oct 21, 25$3.89Oct 23, 25$3.80Oct 27, 25$3.95Oct 29, 25$3.61Oct 31, 25$3.90Nov 4, 25$3.74Nov 6, 25$3.81Nov 10, 25$3.78Nov 12, 25$4.42Nov 14, 25$3.94Nov 18, 25$4.23Nov 20, 25$4.43Nov 25, 25$5.35Nov 28, 25$5.32Dec 2, 25$4.77Dec 4, 25$4.68Dec 8, 25$4.39Dec 10, 25$4.67Dec 12, 25$4.51Dec 16, 25$4.46Dec 18, 25$4.34Dec 22, 25$4.41Dec 24, 25$4.33Dec 29, 25$4.21Jan 2, 26$4.31Jan 6, 26$4.45Jan 8, 26$4.84Jan 12, 26$4.66Jan 14, 26$4.46Jan 16, 26$4.22Jan 21, 26$4.09Jan 23, 26$4.04Jan 27, 26$4.16Jan 29, 26$3.73Feb 2, 26$4.02Feb 4, 26$3.80Feb 9, 26$3.92Feb 11, 26$4.06Feb 13, 26$3.83Feb 18, 26$4.00Feb 20, 26$3.92Feb 24, 26$4.12Feb 26, 26$4.33Mar 2, 26$4.38Mar 4, 26$4.56Mar 6, 26$4.32Mar 10, 26$4.64Mar 12, 26$4.38Mar 17, 26$4.61Mar 19, 26$4.64Mar 23, 26$4.76Mar 25, 26$4.57Mar 27, 26$4.26Mar 31, 26$4.25Apr 2, 26$4.27Apr 7, 26$4.26Apr 9, 26$4.23Apr 13, 26$4.30Apr 15, 26$4.57Apr 17, 26$4.58Apr 22, 26$4.21Apr 24, 26$4.13Apr 28, 26$3.90Apr 30, 26$3.99May 4, 26$4.02May 6, 26$4.11May 8, 26$4.04May 12, 26$4.06May 14, 26$4.11May 18, 26$3.98May 20, 26$3.98May 22, 26$4.06May 28, 26$3.98Jun 1, 26$3.83Jun 3, 26$3.86Jun 5, 26$3.90Jun 9, 26$4.03Jun 11, 26$4.07Jun 15, 26$3.97Jun 17, 26$3.87Jun 22, 26$4.08Jun 24, 26$3.98Jun 26, 26$4.24Jul 2, 26$4.19
$2.3552-week range$5.35
Loading valuation history…

Fundamentals

Key fundamentals

$236.8M

Market cap

1169.2%

Revenue growth (YoY)

99.4%

Gross margin

-$49.5M

Free cash flow (USD)

-$104.8M

Net debt

Net cash position

4.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2020 → 2025

FY 2020$5.7MFY 2021$-782.0KFY 2022$3.5MFY 2023$2.8MFY 2024$2.6MFY 2025$33.5M
$5.7M$33.5M

Free cash flow by year

2020 → 2025

FY 2020$-26.7MFY 2021$-19.7MFY 2022$-29.9MFY 2023$-46.2MFY 2024$-50.8MFY 2025$-49.5M
-$26.7M-$49.5M

Gross margin by year

2021 → 2025

FY 2021125.5%FY 202290.9%FY 202393.3%FY 202492.3%FY 202599.4%
125.5%99.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

5

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 23, 2026Filing
  • Insider sellInsider Sell $58K · 10b5-1 PlanSherman Darren · Director, See Remarks · $58.1KJun 2, 2026Filing
  • Insider buyInsider Buy $19KHochman David P · Director, See Remarks · $19.2KJun 2, 2026Filing
  • Insider buyInsider Buy $2KAryeh Jason · Director · $2.5KMay 20, 2026Filing
  • Insider buyInsider Buy $19KHochman David P · Director, See Remarks · $18.9KMay 19, 2026Filing
  • Insider buyInsider Buy $35KAryeh Jason · Director · $35KMay 19, 2026Filing
  • Insider buyInsider Buy $83KFain Eric S · Director · $82.6KMay 18, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • Insider sellInsider Sell $132RTW INVESTMENTS, LP · 10% Owner · $132.2Apr 29, 2026Filing

Questions

Frequently asked questions

What is Orchestra BioMed Holdings, Inc.'s market cap?

Orchestra BioMed Holdings, Inc. (OBIO) has a market capitalization of $236.8M.

What is OBIO's P/E ratio?

A meaningful P/E ratio is not available for OBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is OBIO's price-to-book (P/B) ratio?

OBIO trades at 3.74 times book value per share.

Are insiders buying OBIO stock?

Yes — SEC Form 4 filings show 5 open-market insider buys and 2 sells at Orchestra BioMed Holdings, Inc. in the last 90 days.

Same arena

Related companies in Biotechnology

CRBU

Caribou Biosciences, Inc.

$235.6M

QSI

Quantum-Si incorporated

$235.4M

VYGR

Voyager Therapeutics, Inc.

$235.3M

SGMT

Sagimet Biosciences Inc.

$235M

WHWK

Whitehawk Therapeutics Inc

$232.4M

ALEC

Alector, Inc.

$242.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.